SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000059478-23-000221
Filing Date
2023-08-08
Accepted
2023-08-08 13:23:19
Documents
71
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lly-20230630.htm   iXBRL 10-Q 2169772
2 EX-31.1 lly-06302023x10qxexhibit311.htm EX-31.1 10589
3 EX-31.2 lly-06302023x10qxexhibit312.htm EX-31.2 10620
4 EX-32 lly-06302023x10qxexhibit32.htm EX-32 7093
  Complete submission text file 0000059478-23-000221.txt   10829898

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20230630.xsd EX-101.SCH 48755
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lly-20230630_cal.xml EX-101.CAL 68379
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20230630_def.xml EX-101.DEF 283787
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20230630_lab.xml EX-101.LAB 706833
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20230630_pre.xml EX-101.PRE 455251
65 EXTRACTED XBRL INSTANCE DOCUMENT lly-20230630_htm.xml XML 2476680
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 231150321
SIC: 2834 Pharmaceutical Preparations